Encres Dubuit, (ALDUB) Fair Value & Analysis
Basic Materials · FR · Market cap €6.3M
Fair value as of: Jun 25, 2026
Analysis
Encres Dubuit, (ALDUB) currently trades at €2.00, while our model-based Fair Value estimate is €2.45 — implying the stock looks roughly 22.5% undervalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
About the company
Encres Dubuit, together with subsidiaries, develops, manufactures, and markets technical inks in France and internationally. It offers UV digital, UV base, solvent-based, pad printing, and other inks. The company also provides technical support services, including customized diagnostics, training and consulting, on-site or remote technical support, and custom development; color matching - colorimetry; screen stretching, such as image processing studio and flashing and typon creation; and silicone pad production. Its products are used in industrial, graphic, cards, visual communication, consumer and printed electronics, label, front panel and small appliances, leisure, plastic and glass packaging, plastics, laboratory products, small surface, textile, and technical glass applications. The company was founded in 1968 and is headquartered in Mitry-Mory, France.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Encres Dubuit, (ALDUB) undervalued?
What is the fair value of ALDUB?
What is the quality score of ALDUB?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.